(CWK) Cushman & Wakefield - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: GB00BFZ4N465

Brokerage, Management, Valuation, Consulting, Facilities

EPS (Earnings per Share)

EPS (Earnings per Share) of CWK over the last years for every Quarter: "2020-12": 0.43, "2021-03": 0.11, "2021-06": 0.5, "2021-09": 0.48, "2021-12": 0.94, "2022-03": 0.48, "2022-06": 0.63, "2022-09": 0.43, "2022-12": 0.46, "2023-03": -0.04, "2023-06": 0.22, "2023-09": 0.21, "2023-12": 0.45, "2024-03": -0.1264, "2024-06": 0.2, "2024-09": 0.23, "2024-12": 0.48, "2025-03": 0.09, "2025-06": 0.3, "2025-09": 0.29,

Revenue

Revenue of CWK over the last years for every Quarter: 2020-12: 2273.1, 2021-03: 1923.8, 2021-06: 2248.3, 2021-09: 2332.9, 2021-12: 2883.7, 2022-03: 2331, 2022-06: 2612.6, 2022-09: 2515.1, 2022-12: 2647, 2023-03: 2249.3, 2023-06: 2406, 2023-09: 2286, 2023-12: 2552.4, 2024-03: 2184.8, 2024-06: 2288, 2024-09: 2344.2, 2024-12: 2629.5, 2025-03: 2284.6, 2025-06: 2483.9, 2025-09: 2605.9,

Dividends

Currently no dividends paid
Risk via 5d forecast
Volatility 36.1%
Value at Risk 5%th 55.2%
Relative Tail Risk -6.94%
Reward TTM
Sharpe Ratio 0.62
Alpha 3.94
CAGR/Max DD 0.18
Character TTM
Hurst Exponent 0.617
Beta 1.241
Beta Downside 1.404
Drawdowns 3y
Max DD 56.72%
Mean DD 25.29%
Median DD 28.89%

Description: CWK Cushman & Wakefield November 09, 2025

Cushman & Wakefield plc (NYSE: CWK) is a global commercial-real-estate services firm operating under the Cushman & Wakefield brand across the Americas, EMEA, and Asia-Pacific. Its service suite spans integrated facilities management, project and development, portfolio administration, transaction management, and strategic consulting, as well as property-management functions such as client accounting, engineering, lease compliance, tenant experience, and sustainability initiatives.

The company also delivers self-performed facilities services-including janitorial, maintenance, critical-environment management, landscaping, and office services-plus workplace and portfolio consulting. In the leasing arena, it offers both owner- and tenant-representation, while its capital-markets arm provides investment-sale advisory, equity and debt financing, structured-finance solutions, and a full range of valuation and advisory services (appraisal, diligence, dispute analysis, litigation support, and financial reporting) for real-estate debt and equity decisions.

Key operational metrics from FY 2023 show total revenue of $9.5 billion, a 5 % year-over-year increase driven largely by higher transaction-management fees and growth in the facilities-management segment. The firm’s global occupancy-rate exposure remains weighted toward North America (≈ 55 % of revenue), where office-space absorption has been stabilizing after a pandemic-induced dip, while demand for industrial and logistics space continues to outpace supply, supporting higher fee yields in that sub-sector.

Macro-level drivers that will shape Cushman & Wakefield’s outlook include the trajectory of U.S. interest rates-higher rates can suppress real-estate investment activity but also boost demand for advisory services that help clients navigate financing constraints-and the ongoing shift toward hybrid work models, which is prompting tenants to re-evaluate space utilization and seek flexible-lease solutions, a niche where the firm’s consulting capabilities are increasingly valuable.

For a deeper, data-driven assessment of CWK’s valuation assumptions and scenario-based forecasts, the ValueRay platform provides a transparent framework that can help you test the sensitivity of key drivers.

Piotroski VR‑10 (Strict, 0-10) 2.0

Net Income (223.5m TTM) > 0 and > 6% of Revenue (6% = 600.2m TTM)
FCFTA 0.02 (>2.0%) and ΔFCFTA -0.96pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 1.66% (prev 4.35%; Δ -2.70pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.03 (>3.0%) and CFO 198.3m <= Net Income 223.5m (YES >=105%, WARN >=100%)
Net Debt (2.48b) to EBITDA (569.2m) ratio: 4.35 <= 3.0 (WARN <= 3.5)
Current Ratio 1.07 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (235.9m) change vs 12m ago 1.07% (target <= -2.0% for YES)
Gross Margin 17.81% (prev 17.89%; Δ -0.08pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 131.4% (prev 124.4%; Δ 7.05pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 1.02 (EBITDA TTM 569.2m / Interest Expense TTM 450.1m) >= 6 (WARN >= 3)

Altman Z'' -0.02

(A) 0.02 = (Total Current Assets 2.67b - Total Current Liabilities 2.51b) / Total Assets 7.69b
(B) -0.11 = Retained Earnings (Balance) -875.3m / Total Assets 7.69b
(C) 0.06 = EBIT TTM 460.9m / Avg Total Assets 7.61b
(D) -0.19 = Book Value of Equity -1.06b / Total Liabilities 5.73b
Total Rating: -0.02 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 49.64

1. Piotroski 2.0pt
2. FCF Yield 2.87%
3. FCF Margin 1.78%
4. Debt/Equity 1.59
5. Debt/Ebitda 4.35
6. ROIC - WACC (= 4.17)%
7. RoE 12.09%
8. Rev. Trend -24.71%
9. EPS Trend -49.15%

What is the price of CWK shares?

As of December 29, 2025, the stock is trading at USD 16.53 with a total of 786,093 shares traded.
Over the past week, the price has changed by +2.16%, over one month by -2.02%, over three months by +4.16% and over the past year by +24.01%.

Is CWK a buy, sell or hold?

Cushman & Wakefield has received a consensus analysts rating of 3.40. Therefor, it is recommend to hold CWK.
  • Strong Buy: 1
  • Buy: 3
  • Hold: 5
  • Sell: 1
  • Strong Sell: 0

What are the forecasts/targets for the CWK price?

Issuer Target Up/Down from current
Wallstreet Target Price 18 8.9%
Analysts Target Price 18 8.9%
ValueRay Target Price 16.4 -0.8%

CWK Fundamental Data Overview December 28, 2025

Market Cap USD = 3.75b (3.75b USD * 1.0 USD.USD)
P/E Trailing = 17.0316
P/E Forward = 13.3511
P/S = 0.3746
P/B = 1.9144
P/EG = 0.6013
Beta = 1.462
Revenue TTM = 10.00b USD
EBIT TTM = 460.9m USD
EBITDA TTM = 569.2m USD
Long Term Debt = 2.72b USD (from longTermDebt, last quarter)
Short Term Debt = 129.2m USD (from shortTermDebt, last quarter)
Debt = 3.11b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.48b USD (from netDebt column, last quarter)
Enterprise Value = 6.22b USD (3.75b + Debt 3.11b - CCE 634.4m)
Interest Coverage Ratio = 1.02 (Ebit TTM 460.9m / Interest Expense TTM 450.1m)
FCF Yield = 2.87% (FCF TTM 178.5m / Enterprise Value 6.22b)
FCF Margin = 1.78% (FCF TTM 178.5m / Revenue TTM 10.00b)
Net Margin = 2.23% (Net Income TTM 223.5m / Revenue TTM 10.00b)
Gross Margin = 17.81% ((Revenue TTM 10.00b - Cost of Revenue TTM 8.22b) / Revenue TTM)
Gross Margin QoQ = 16.43% (prev 17.76%)
Tobins Q-Ratio = 0.81 (Enterprise Value 6.22b / Total Assets 7.69b)
Interest Expense / Debt = 1.80% (Interest Expense 56.0m / Debt 3.11b)
Taxrate = -13.97% (negative due to tax credits) (-6.30m / 45.1m)
NOPAT = 525.3m (EBIT 460.9m * (1 - -13.97%)) [negative tax rate / tax credits]
Current Ratio = 1.07 (Total Current Assets 2.67b / Total Current Liabilities 2.51b)
Debt / Equity = 1.59 (Debt 3.11b / totalStockholderEquity, last quarter 1.96b)
Debt / EBITDA = 4.35 (Net Debt 2.48b / EBITDA 569.2m)
Debt / FCF = 13.87 (Net Debt 2.48b / FCF TTM 178.5m)
Total Stockholder Equity = 1.85b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.91% (Net Income 223.5m / Total Assets 7.69b)
RoE = 12.09% (Net Income TTM 223.5m / Total Stockholder Equity 1.85b)
RoCE = 10.09% (EBIT 460.9m / Capital Employed (Equity 1.85b + L.T.Debt 2.72b))
RoIC = 10.89% (NOPAT 525.3m / Invested Capital 4.82b)
WACC = 6.72% (E(3.75b)/V(6.86b) * Re(10.59%) + D(3.11b)/V(6.86b) * Rd(1.80%) * (1-Tc(-0.14)))
Discount Rate = 10.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.09%
[DCF Debug] Terminal Value 61.47% ; FCFE base≈206.0m ; Y1≈143.5m ; Y5≈73.8m
Fair Price DCF = 4.25 (DCF Value 985.1m / Shares Outstanding 231.6m; 5y FCF grow -35.61% → 3.0% )
EPS Correlation: -49.15 | EPS CAGR: -26.92% | SUE: 0.36 | # QB: 0
Revenue Correlation: -24.71 | Revenue CAGR: -2.67% | SUE: 0.42 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.12 | Chg30d=-0.004 | Revisions Net=-1 | Analysts=8
EPS next Year (2026-12-31): EPS=1.45 | Chg30d=-0.018 | Revisions Net=+0 | Growth EPS=+19.2% | Growth Revenue=+5.6%

Additional Sources for CWK Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle